haplotypes in the controls (P G 0.0001). The frequency of sequence variants within the CFH coding region on the associated haplotype was significantly reduced in cases compared to controls (12% versus 18%, P 0 0.002). When the overrepresented T1277C variant was removed from the analysis, this difference became more pronounced (3% versus 16%, P G 0.00001). Thus, T1277C is the primary DNA sequence variant differentiating between the case and control haplotypes.
Complete genotyping of T1277C in the family-based and case-control data sets revealed a significant overtransmission in the families (P 0 0.019) (12) and a highly significant overrepresentation in the cases compared to controls (P 0 0.00006). The odds ratio for AMD was 2.45 E95% confidence interval (CI): 1.41 to 4.25^for carriers of one C allele and 3.33 (95% CI: 1.79 to 6.20) for carriers of two C alleles. When the analysis was restricted to only neovascular AMD, these odds ratios increased to 3.45 (95% CI: 1.72 to 6.92) and 5.57 (95% CI: 2.52 to 12.27) , respectively. This apparent dose effect for risk associated with the C allele was highly significant (P G 0.0001). There was no apparent allelic or genotypic effect of T1277C on age at AMD diagnosis (mean age at diagnosis: TT, 76.5 years; TC, 77.5 years; CC, 75.5 years). The population attributable risk percent for carrying at least one C allele was 43% (95% CI: 23 to 68%).
The Y402H variant is predicted to have functional consequences consistent with AMD pathology. Residue 402 is located within binding sites for heparin (18) and C-reactive protein (CRP) (19) . Binding to either of these partners increases the affinity of CFH for the complement protein C3b (20, 21) , augmenting its ability to down-regulate complement_s effect. The observed colocalization of CFH, CRP, and proteoglycans in the superficial layer of the arterial intima suggests that CFH may protect the host arterial wall from excess complement activation (22) . We hypothesize that allele-specific changes in the activities of the binding sites for heparin and CRP would alter CFH_s ability to suppress complementrelated damage to arterial walls and might ultimately lead to vessel injury and subsequent neovascular/exudative changes such as those seen in neovascular AMD. Our data support this hypothesis, because the risk associated with the C allele is more pronounced when the analyses are restricted to neovascular AMD. Given the known functional interactions of genes within the RCA gene cluster (13) , variants within these genes could interact with or modify the effect of the T1277C variant.
Plasma levels of CFH are known to decrease with smoking (23), a known risk factor for AMD (2) . This confluence of genetic and environmental risk factors suggests an integrated etiological model of AMD involving chronic inflammation. Identification of the increased risk of AMD associated with the T1277C variant should enhance our ability to develop presymptomatic tests for AMD, possibly allowing earlier detection and better treatment of this debilitating disorder. Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association (P 0 4.95 Â 10 j10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 Y histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
AMD is a leading cause of blindness in older individuals (1) . It is a late-onset, complex trait with hereditary, lifestyle, and medical risk factors (2) . The condition typically presents in the fifth decade of life with small yellow deposits external to the outer retina and retinal pigment epithelium (RPE) called drusen. Large numbers of drusen and clinical features of damage to the RPE markedly increase the risk of complications (atrophy of the RPE and abnormal neovascularization of the outer retina), leading to severe vision loss (1) .
Although the primary pathogenic mechanisms of AMD were previously unknown, there is strong evidence that genetics plays a role (3) (4) (5) (6) (7) (8) (9) . The first locus for AMD (ARMD1) was reported in a single extended family linked to chromosome 1q25.3-31.3 (5). Because there was strong evidence for linkage to this region of chromosome 1 ( fig. S1 ) from subsequently reported small family studies, we focused our efforts on the ARMD1 locus (3, 4, 6, 8, 9) .
We performed an allele association study on a new case-control population that is highly discordant for clinical phenotypes. Cases were enrolled on the basis of ocular features (extensive drusen or pigmentary abnormalities of the macula) placing subjects at high risk for development of the complications of AMD or the presence of those complications in one or both eyes (10) . Control subjects were from the same patient population and could have no more than four small hard drusen in the central retina (macula) and no known family history of AMD. A subset of 224 cases and 134 controls meeting these criteria were selected as a discovery sample for initial genotyping (table S1). The discovery sample was enriched for AMD cases showing familial clustering of AMD and high-risk, early AMD. A second, replication sample of 176 cases and 68 controls was ascertained at the same clinic following the same protocol (table S1) .
Evaluation of the reported Gln 5346 Y Arg 5346 variation in the fibulin 6 gene (FIBL6) and 23 single-nucleotide polymorphisms (SNPs) across this gene Esupporting online material (SOM) text^gave no evidence for allele or haplotype association in the discovery sample (11) . To determine whether common coding sequence variation within the ARMD1 locus was associated with AMD, we searched publicly available databases for nonsynonymous coding SNPs (nscSNPs). We identified 24 nscSNPs with known minor allele frequencies of at least 10% across the 14-Mb ARMD1 locus. Genotyping of the discovery sample gave significant allele and genotype association between AMD and nscSNPs only within the regulation of complement activation (RCA) locus in chromosome 1q31.3 (table S2) . Additional evenly spaced, gene-based SNPs were evaluated across all 31 genes in clusters 1, 3, 4, and 6 at 8-kb to 25-kb density ( fig. S1 ), and no associations with AMD were detected outside of the RCA locus (table S3) . These data suggest that the RCA locus contains one or more genetic variants that increase the risk of developing AMD.
The RCA locus spans 388 kb of genomic DNA that contains the gene encoding complement factor H (CFH), five genes derived from CFH through ancestral duplications, and the gene encoding factor 13B (Fig. 1) . A total of 86 SNPs located across the RCA locus and flanking regions were genotyped. Twenty-nine gave evidence for allele association with the majority, and the most significant of these, including the nscSNP rs1061170, concentrated in the CFH gene (table S3, GenBank accession no. NM_000186).
The genotype frequency data for rs1061170 revealed that the association with AMD was largely due to an excess of CC homozygotes in cases compared with controls (Table 1) . A similar pattern of association was evident with seven adjacent SNPs in CFH (Fig. 1 and  table S3 ). The strength of the evidence for association diminished markedly with SNPs located immediately proximal to CFH and distal to its derivatives CFHL1 to CFHL5, suggesting that the effect was due to one or more polymorphisms in the complement factor genes only ( Fig. 1 and table S3 ).
Haplotype analyses of 34 SNPs spanning 418 kb revealed extensive linkage disequilibrium across the full length of the RCA locus (Fig. 2) . The highest level of linkage disequilibrium was discernable among four haplotype blocks across the RCA locus. Thirteen contiguous SNPs in CFH (i.e., all but the first two CFH SNPs in Fig. 2 ) form a 64-kb haplotype block. A second 9-kb haplotype block contained SNPs in the proximal portion of CFHL4, a third 50-kb block contained SNPs in the distal portion of CFHL4 and in CFHL2, and a fourth 146-kb block contained SNPs in F13B, ASPM, and FRBZ1 (Fig. 2) . The SNPs most significantly associated with AMD were in CFH or within 221 kb downstream of CFH ( Fig. 1 and table S3 ). The association between AMD and haplotypes comprising two to five contiguous SNPs was evaluated by using the Haplo.stat software and a sliding window approach (12, 13) . Additional comparisons were made by using all possible haplotypes formed by pairwise combinations, including at least one nscSNP within the RCA locus. The analysis did not reveal any SNP combination showing greater association with AMD than the individual SNPs. All of the AMD high-risk haplotypes, including a CFH SNP from haplotype block 1 and a non-CFH SNP from other regions of the RCA locus (Fig. 1) , contained the AMD risk allele from the CFH SNP but not necessarily the AMD risk allele from the non-CFH SNP. These analyses provide further evidence that the multiple signals in the RCA locus are related to a single haplotype and therefore likely caused by a single genetic effect.
To verify these findings, we genotyped 14 SNPs in the RCA locus in the replication sample. Association with AMD was observed with the seven markers that were significant in the discovery sample, including rs1061170, but not with the seven markers yielding negative results in the discovery sample (table S4) . Notably, the genotype frequencies for rs1061170 among cases enriched for a positive family history of AMD were nearly identical to the frequencies among cases without this characteristic ( Table 1 ), suggesting that this CFH protein polymorphism is a risk factor for AMD more generally. Taking into account data from the entire sample, a conservative estimation of the relative risk for AMD conferred by having at least one C allele (i.e., having either the CC or CT genotypes) was 2.7 (95% confidence interval of 1.9 to 3.9).
Complement activation has been implicated in the pathogenesis of a number of complex traits, including AMD, and can arise through the classical, lectin, or alternative pathways (14) . All three pathways lead to the generation of a C3 convertase enzyme and subsequent activation of the immune response, the terminal pathway pore-like membrane attack complex (C5b-9), and cell lysis. The alternative complement pathway is spontaneously activated, and CFH is an essential inhibitor preventing uncontrolled complement activation (15) . Components of the terminal complement pathway and other markers of inflammation are deposited in drusen and the choroid of eyes with AMD (16, 17) . Abnormal regulation of the alternative pathway of complement activation by CFH is consistent with these observations.
The tyrosine-to-histidine polymorphism (rs1061170) at amino acid 402 of CFH may be a primary pathogenic variation increasing the risk of developing AMD. CFH is composed of 20 repetitive units of 60 amino acids called short consensus repeats (SCRs). The Try 402 Y His 402 polymorphism is located within SCR7, which contains the overlapping binding sites for heparin, C-reactive protein (CRP), and M protein (18) . Serum amounts of CRP were elevated in AMD subjects compared with controls in one large prospective clinical trial (19) . CRP activates the classic complement pathway but reduces deposition of C5b-9 through the direct binding of CFH (20) . Risk factors for development of complications of AMD, including cigarette smoking, lack of exercise, hypertension, and obesity (2, 21), increased serum CRP or decreased serum CFH (22) (23) (24) (25) . Further, drusen with terminal complement deposition indistinguishable from AMD were observed in eyes from patients with a kidney disease (membranoproliferative glomerulonephritis type II) that can be caused by mutations in CFH (26, 27 More than 7 million individuals in the United States have retinal features placing them at high risk for developing vision loss from complications of AMD (28) . The attributable fraction for the C allele derived from the total sample of subjects in this study is 50%, suggesting that persons either homo- indicates complete linkage equilibrium. By using the Haploview version 3.0 software, we could divide the RCA locus into four haplotype blocks (29) . D ¶ values for all or nearly all pairwise comparisons within a haplotype block are at least 0.8 (black squares). The haplotype block structure is similar to that obtained by the HapMap Project for this region in Caucasians, with the notable difference that blocks 2 and 3 in our structure compose one block in the HapMap report (10) . The lone SNP (rs379370) between blocks 2 and 3 is a nscSNP in the CFHL4 gene (table S2) showing moderate LD (gray squares), modest LD (light gray squares), or low LD (white squares) with the SNPs in block 3.
zygous or heterozygous for histidine at amino acid 402 of CFH may account for one-half of AMD cases. Given the rapid aging of the population, an estimated 3 million individuals will have atrophic and exudative complications of AMD by 2020 (28) . Our findings suggest previously unknown avenues for developing preventative and therapeutic strategies for AMD.
